Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)
Sponsor: Mst.Sumyara Khatun
Summary
The goal of this clinical trial is to learn if drug Drospirenone ethinyl estradiol works better than drug Cyproterone acetate ethinyl estradiol to treat PCOS. The main questions it aims to answer are What medical problems do participants have when taking drug Drospirenone ethinyl estradiol and Cyproterone acetate ethinyl estradiol? Researchers will compare drug Drospirenone ethinyl estradiol to drug Cyproterone acetate ethinyl estradiol to see if drug Drospirenone ethinyl estradiol works better than Cyproterone acetate ethinyl estradiol to treat PCOS. Participants will: Take drug Drospirenone ethinyl estradiol or Cyproterone acetate ethinyl estradiol every day for 3 months Visit the clinic after 3 months for checkups and tests Keep a diary of their symptoms
Key Details
Gender
FEMALE
Age Range
20 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-07-01
Completion Date
2024-12-31
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
DRSP-EE (Experimental) group received DRSP-EE 1 tab daily (one active pill daily for 21 days and 7 inactive pills) for three cycles
DRSP-EE (Experimental) group received DRSP-EE 1 tab daily (one active pill daily for 21 days and 7 inactive pills) for three cycles
.CPA-EE (Comparator) groupreceivedCPA-EE 1 tab daily (one active pill daily for 21 days and 7 pill free days) for three cycles
.CPA-EE (Comparator) groupreceivedCPA-EE 1 tab daily (one active pill daily for 21 days and 7 pill free days) for three cycles
Locations (1)
Bangladesh Medical University
Dhaka, Bangladesh